Patent Woes Threaten Drug Firms
The New York Times At the end of November, Pfizer stands to lose a $10-billion-a-year revenue stream when the patent on its blockbuster cholesterol drug Lipitor expires and cheaper generics begin to cut into the company’s huge sales. The loss poses a daunting challenge for Pfizer,…
